Dr. Katz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
# 647
Rochester, NY 14642Phone+1 585-275-2171Fax+1 585-275-1531
Education & Training
- Tel Aviv University SacklerClass of 1985
Certifications & Licensure
- MA State Medical License 2023 - 2026
- NC State Medical License 2023 - 2025
- NY State Medical License 1985 - 2025
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Pre-operative Stereotactic Body Radiation Therapy for Pancreatic Adenocarcinoma With or Without CCX872-B Start of enrollment: 2019 Aug 01
Publications & Presentations
PubMed
- 57 citationsTrastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial.Howard P Safran, Kathryn Winter, David H Ilson, Dennis Wigle, Thomas DiPetrillo
The Lancet. Oncology. 2022-02-01 - 7 citationsRefining the definition of biochemical failure in the era of stereotactic body radiation therapy for prostate cancer: The Phoenix definition and beyond.Ting Martin Ma, Soumyajit Roy, Xue Wu, Constantine Mantz, Donald B. Fuller
Radiotherapy and Oncology. 2022-01-01 - 30 citationsModulation of the Human Pancreatic Ductal Adenocarcinoma Immune Microenvironment by Stereotactic Body Radiotherapy.Bradley N. Mills, Haoming Qiu, Michael G. Drage, Chunmo Chen, Jocelyn S Mathew
Clinical Cancer Research. 2021-12-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: